Pharmacological Modulation of Dopamine Receptor D2-Mediated Transmission Alters the Metabolic Phenotype of Diet Induced Obese and Diet Resistant C57Bl6 Mice
Figure 2
Fasting plasma glucose (a), insulin (b), and NEFA (c) concentrations in DIO and DR mice after treatment with bromocriptine (BC), haloperidol (HP), or placebo (P) for 2 weeks. Data is presented as mean ± SD for 9 or 10 mice per group. *; **.